Literature DB >> 19330221

Mitochondrial alterations in dynamin 2-related centronuclear myopathy.

Edmar Zanoteli1, Naja Vergani, Yvan Campos, Mariz Vainzof, Acary S B Oliveira, Alessandra d'Azzo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19330221     DOI： 10.1590/s0004-282x2009000100023

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN： 0004-282X            Impact factor:   1.420


× No keyword cloud information.
  4 in total

1.  Increased expression of wild-type or a centronuclear myopathy mutant of dynamin 2 in skeletal muscle of adult mice leads to structural defects and muscle weakness.

Authors:  Belinda S Cowling; Anne Toussaint; Leonela Amoasii; Pascale Koebel; Arnaud Ferry; Laurianne Davignon; Ichizo Nishino; Jean-Louis Mandel; Jocelyn Laporte
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations.

Authors:  F Hanisch; T Müller; A Dietz; M Bitoun; W Kress; J Weis; G Stoltenburg; S Zierz
Journal:  J Neurol       Date:  2011-01-09       Impact factor: 4.849

3.  Mice lacking microRNA 133a develop dynamin 2–dependent centronuclear myopathy.

Authors:  Ning Liu; Svetlana Bezprozvannaya; John M Shelton; Madlyn I Frisard; Matthew W Hulver; Ryan P McMillan; Yaru Wu; Kevin A Voelker; Robert W Grange; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  J Clin Invest       Date:  2011-08       Impact factor: 14.808

4.  Characterization of a novel zebrafish model of SPEG-related centronuclear myopathy.

Authors:  Karla G Espinosa; Salma Geissah; Linda Groom; Jonathan Volpatti; Ian C Scott; Robert T Dirksen; Mo Zhao; James J Dowling
Journal:  Dis Model Mech       Date:  2022-05-09       Impact factor: 5.732
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.